News from the healthcare data industry
We recently commissioned a review into our usage of real world evidence (RWE) and patient reported outcomes (PROs) in the regulation of medicines and medical devices. This considered stakeholders’ understanding...
By Stacy Cline Amin, Morrison & Foerster; former chief counsel of the FDA Health policy experts have talked excitedly about the potential for real-world evidence (RWE) to transform healthcare delivery...
BOSTON, Nov. 5, 2021 /PRNewswire/ — Analysis Group, a global leader in health economics and outcomes research (HEOR) and regulatory epidemiology, today announced the publication of research examining the US Food and Drug...
DUBLIN, Ohio, Oct. 28, 2021 /PRNewswire/ — Cardinal Health (NYSE: CAH) announced today it has been awarded a $750,000 contract by the U.S. Food and Drug Administration (FDA) to implement an 18-month real world evidence (RWE)...
Newswise — Lawrenceville, NJ, USA—October 26, 2021—ISPOR—The Professional Society for Health Economics and Outcomes Research announced today that the Real-World Evidence Transparency Initiative has launched the Real-World Evidence Registry. The Real-World Evidence Transparency...
NEW YORK, NY, October 21, 2021 — Today, Aetion announces that it is expanding its relationship with the U.S. Food and Drug Administration (FDA) to use real-world evidence (RWE) to study...
PHILADELPHIA, Oct. 7, 2021 /PRNewswire/ — HealthVerity, Inc., the leader in Identity, Privacy, Governance, and Exchange (IPGE) for real-world data, today announced that it has been awarded a contract with the Centers for Disease...
Collaboration will leverage the Aetion Evidence Platform® to study when and how RWE can support the agency’s decision-making NEW YORK, NY & MANCHESTER, ENGLAND, October 6, 2021 — Aetion today announced a collaboration...
October 04, 2021 06:59 AM Eastern Daylight Time DENVER–(BUSINESS WIRE)–Palantir Technologies Inc. (NYSE:PLTR), a leading builder of operating systems for the modern enterprise, announced today the National Institutes of Health’s...
October 1, 2021 Jill Wechsler, Pharm Exec’s Washington Correspondent Demand for more efficient and faster development of medical products is prompting regulatory authorities to incorporate additional sources of information into...